Thrombolytic Therapy in Pediatric Patients: A Comprehensive Review of the Literature

• References

• 1 TIMI Study Group. The thrombolysis in myocardial infarction trial. N Engl JMed 1985; 312: 932-936
• 2 Verstraete M, Bernard R, Bory M, Brower RW, Collen D, de Bono DP, Erbel R, Huhmann W, Lennane RJ, Lubsen J. Randomized trial of intravenous recombinant human tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Lancet 1985; 1: 842-848
• 3 Goldhaber S, Kessler C, Heit J, Markis J, Sharma GV, Dawley D, Nagel JS, Meyerovitz M, Kim D, Vaughan DE. Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet 1988; 2: 293-298
• 4 Verstraete M, Miller G, Bounameaux H, Charbonnier B, Colle JP, Lecorf G, Marbet GA, Mombaerts P, Olsson CG. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988; 77: 353-360
• 5 Turpie A. Thrombolytic therapy in venous thromboembolism. In: Tissue plasminogen activator in thrombolytic therapy Sobel B, Collen D, Grossbard E. eds. New York, Marcel Dekker: 1987: 131-146
• 6 Collen D, Topal E, Tiefenbrun A, Gold HK, Weisfeld ML, Sobel BE, Leinbach RC, Brinker JA, Ludbrook PA, Yasuda I. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized placebo controlled trial. Circulation 1984; 70: 1012-1017
• 7 Anglo-Scandinavian Study of Thrombolysis (ASSET). Trial of tissue plasminogen activator or mortality reduction in acute myocardial infarction. Lancet 1988 2. 525-530
• 8 Vailas G, Brouillette R, Scott J, Shkolnik A, Conway J, Wiringa K. Neonatal aortic thrombosis: recent experience. J Pediatr 1986; 109: 101-108
• 9 Emami J, Saldanha R, Knupp C, Kodroff M. Failure of systemic thrombolytic and heparin therapy in the treatment of neonatal aortic thrombosis. Pediatrics 1987; 79: 773
• 10 Pyles L, Pierpont M, Steiner M. et al. Fibrinolysis by tissue plasminogen activator in a child with pulmonary embolism. J Pediatr 1990; 116 (05) 801-804
• 11 Andrew M, Brooker L, Paes B, Weitz J. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemostas 1992; 68 (03) 325-330
• 12 Mazzucconi MG, Francesconi M, Fidani P, Conti L, Martelli MC, Paesano R, Pachi A, Purpura M, Gandolfo GM. Pregnancy, delivery and detection of antiplatelet antibodies in women with idiopathic thrombocytopenic purpura. Haematologica (Pavia) 1985; 70: 506-509
• 13 Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen D, Powers P. Development of the human coagulation system in the full-term infant. Blood 1987; 70 (01) 165-172
• 14 Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12: 95-104
• 15 Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen D, Castle V, Powers P. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-1657
• 16 Deeg K, Wolfel D, Rupprecht T. Diagnosis of neonatal aortic thrombosis by colour coded Doppler sonography. Pediatr Radiol 1992; 22 (01) 62-63